AQUINOX PHARMACEUTICALS, INC (AQXP) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 184 transactions totaling $139.7M, demonstrating a bullish sentiment with $54.3M in net insider flow. The most recent transaction on Aug 7, 2019 involved a purchase of 531 shares valued at $1.6K.
No significant insider buying has been recorded for AQXP in the recent period.
No significant insider selling has been recorded for AQXP in the recent period.
Based on recent SEC filings, insider sentiment for AQXP is bullish with an Insider Alignment Score of 69/100 and a net flow of $54.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AQUINOX PHARMACEUTICALS, INC (AQXP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading AQXP stock, having executed 184 transactions in the past 90 days. The most active insider is Felix Baker (Executive), who has made 29 transactions totaling $75.3M.
Get notified when executives and directors at AQXP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 531 | $2.96 | $1.6K | |
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 5,869 | $2.96 | $17.4K | |
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 18,943 | $3.02 | $57.2K | |
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 209,382 | $3.02 | $632.3K | Large |
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 4,564 | $3.15 | $14.4K | |
| Aug 7, 2019 | Baker Felix | Executive | Purchase | 50,436 | $3.15 | $158.9K | |
| Aug 6, 2019 | Baker Felix | Executive | Purchase | 65,568 | $2.85 | $186.9K | |
| Aug 6, 2019 | Baker Felix | Executive | Purchase | 9,445 | $2.83 | $26.7K | |
| Aug 6, 2019 | Baker Felix | Executive | Purchase | 5,932 | $2.85 | $16.9K | |
| Aug 6, 2019 | Baker Felix | Executive | Purchase | 855 | $2.83 | $2.4K | |
| May 14, 2018 | J. Levitt Daniel | Executive | Option Exercise | 3,906 | $10.56 | $41.2K | |
| May 14, 2018 | J. Levitt Daniel | Executive | Sale | 3,906 | $12.67 | $49.5K | |
| Mar 15, 2018 | Mackenzie Lloyd | Executive | Sale | 1,302 | $14.63 | $19.0K | |
| Mar 15, 2018 | Mackenzie Lloyd | Executive | Option Exercise | 1,302 | $10.56 | $13.7K | |
| Jun 5, 2017 | Main David | Executive | Sale | 3,625 | $13.16 | $47.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 110 | $97.0M | 69.1% |
Sale(S) | 42 | $42.7M | 30.4% |
Exercise(M) | 9 | $579.2K | 0.4% |
Disposition(D) | 13 | $104.0K | 0.1% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Insiders at AQUINOX PHARMACEUTICALS, INC are accumulating shares at an accelerated pace. With 15 insiders making 184 transactions totaling $97.0M in purchases versus $42.7M in sales, the net buying activity of $54.3M signals strong executive confidence. Felix Baker (Executive) leads the buying activity with $75.3M in transactions across all time.